Sabine Adler

3.6k total citations · 1 hit paper
43 papers, 1.6k citations indexed

About

Sabine Adler is a scholar working on Rheumatology, Pulmonary and Respiratory Medicine and Molecular Biology. According to data from OpenAlex, Sabine Adler has authored 43 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Rheumatology, 15 papers in Pulmonary and Respiratory Medicine and 8 papers in Molecular Biology. Recurrent topics in Sabine Adler's work include Vasculitis and related conditions (10 papers), Otitis Media and Relapsing Polychondritis (7 papers) and Systemic Sclerosis and Related Diseases (6 papers). Sabine Adler is often cited by papers focused on Vasculitis and related conditions (10 papers), Otitis Media and Relapsing Polychondritis (7 papers) and Systemic Sclerosis and Related Diseases (6 papers). Sabine Adler collaborates with scholars based in Switzerland, Germany and France. Sabine Adler's co-authors include Peter M. Villiger, Stephan Reichenbach, Felix Wermelinger, Lukas Bütikofer, Michael Seitz, Stefan Kuchen, Diana Dan, Harald Bonél, Bradley T. Thach and Ivan D. Frantz and has published in prestigious journals such as The Lancet, SHILAP Revista de lepidopterología and Journal of the American College of Cardiology.

In The Last Decade

Sabine Adler

35 papers receiving 1.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Tocilizumab for induction and maintenance of remission in giant cell arteritis: a phase 2, randomised, double-blind, placebo-controlled trial

2016 377 citations Peter M. Villiger, Sabine Adler et al. The Lancet profile →

Peers

Countries citing papers authored by Sabine Adler

Since Specialization

Citations

This map shows the geographic impact of Sabine Adler's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sabine Adler with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sabine Adler more than expected).

Fields of papers citing papers by Sabine Adler

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sabine Adler. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sabine Adler. The network helps show where Sabine Adler may publish in the future.

Co-authorship network of co-authors of Sabine Adler

This figure shows the co-authorship network connecting the top 25 collaborators of Sabine Adler. A scholar is included among the top collaborators of Sabine Adler based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sabine Adler. Sabine Adler is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Anti-CD74 autoantibodies in axial spondyloarthritis as biomarkers for activity and severity of disease but not for tumour necrosis factor inhibitor retention: data from the Swiss Clinical Quality Management in rheumatic diseases cohort 2025 ·Clinical Rheumatology ·(unknown), (unknown), Torsten Witte, Almut Scherer, (unknown), Michael J. Nissen, Burkhard Möller, (unknown), Diego Kyburz, Diana Dan, Andrea Rubbert‐Roth, Sabine Adler, Oliver Distler, Xenofon Baraliakos, Adrian Ciurea	0
2	Concomitant Sjögren’s disease as a biomarker for treatment effectiveness in rheumatoid arthritis - results from the Swiss clinical quality management cohort 2024 ·Arthritis Research & Therapy ·(unknown), (unknown), Axel Finckh, Benjamin A. Fisher, Sabine Adler, Britta Maurer, Burkhard Möller, (unknown)	2
3	Immunglobulin-A-Vaskulitis 2024 ·Die Innere Medizin ·Sabine Adler	0
4	Management of giant-cell arteritis in Switzerland: an online national survey 2023 ·Swiss Medical Weekly ·Michele Iudici, (unknown), Mihaela Stegert, (unknown), Sabine Adler, Mike Oliver Becker, Christoph T. Berger, Diana Dan, Axel Finckh, Alfred Mahr, Thomas Neumann, Stephan Reichenbach, Camillo Ribi, Luca Seitz, Peter M. Villiger, Lukas Wildi, Thomas Daikeler, (unknown)	0
5	(p)ppGpp and moonlighting RNases influence the first step of lipopolysaccharide biosynthesis in Escherichia coli 2023 ·PubMed ·(unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Sabine Adler, Dominik Begerow, Wieland Steinchen, Gert Bange, Franz Narberhaus	7
6	Low-dose radiotherapy for greater trochanteric pain syndrome—a single-centre analysis 2023 ·Strahlentherapie und Onkologie ·(unknown), Silvia Gómez, Susanne Rogers, István Takács, Thomas Kern, Sabine Adler, Dieter Cadosch, Oliver Riesterer	2
7	The Joint Vasculitis Registry in German-speaking countries (GeVas) – a prospective, multicenter registry for the follow-up of long-term outcomes in vasculitis 2021 ·BMC Rheumatology ·Christof Iking‐Konert, (unknown), (unknown), Sabine Adler, Kirsten de Groot, Bernhard Hellmich, Bimba F. Hoyer, Konstanze Holl‐Ulrich, Gabriele Ihorst, (unknown), Ina Kötter, Ulf Müller‐Ladner, Tim Magnus, Jürgen Rech, (unknown), Hendrik Schulze‐Koops, Nils Venhoff, Thorsten Wiech, Peter M. Villiger, Peter Lamprecht	4
8	Clinically established biodegradable long acting injectables: An industry perspective 2020 ·Advanced Drug Delivery Reviews ·Christian Isalomboto Nkanga, Andreas Fisch, Mazda Rad‐Malekshahi, Marieta Duvnjak Romić, Birgit Kittel, Thomas Ullrich, Jing Wang, Rui W. M. Krause, Sabine Adler, Twan Lammers, Wim E. Hennink, Farshad Ramazani	115
9	ACE inhibitors in SSc patients display a risk factor for scleroderma renal crisis—a EUSTAR analysis 2020 ·Arthritis Research & Therapy ·(unknown), Lukas Bütikofer, (unknown), Oliver Distler, Otylia Kowal‐Bielecka, Yannick Allanore, (unknown), Peter M. Villiger, Sabine Adler	41
10	Behçet’s syndrome: clinical presentation and prevalence in Switzerland 2019 ·Swiss Medical Weekly ·(unknown), Ana‐Luisa Stefanski, (unknown), Sabine Adler, Peter M. Villiger	4
11	Peripheral and central nervous system involvement in a patient with primary Sjögren’s syndrome: a case report 2019 ·Journal of Medical Case Reports ·(unknown), Marie‐Luise Mono, Mathias Sturzenegger, (unknown), Sabine Adler, Vera Genitsch, Franca Wagner	3
12	Systemic sclerosis associated interstitial lung disease - individualized immunosuppressive therapy and course of lung function: results of the EUSTAR group 2018 ·Arthritis Research & Therapy ·Sabine Adler, Dörte Huscher, Elise Siegert, Yannick Allanore, László Czirják, (unknown), Christopher P. Denton, Oliver Distler, M. Frerix, Marco Matucci‐Cerinic, Ulf Müeller-Ladner, (unknown), Gabriele Valentini, Ulrich A. Walker, Peter M. Villiger, Gabriela Riemekasten	67
13	Tocilizumab for induction and maintenance of remission in giant cell arteritis: a phase 2, randomised, double-blind, placebo-controlled trial breakdown → 2016 ·The Lancet ·Peter M. Villiger, Sabine Adler, Stefan Kuchen, Felix Wermelinger, Diana Dan, (unknown), Lukas Bütikofer, Michael Seitz, Stephan Reichenbach	377
14	Home parenteral nutrition is beneficial in systemic sclerosis patients with gastrointestinal dysfunction 2015 ·Scandinavian Journal of Rheumatology ·Zeno Stanga, (unknown), P Schärer, Agnes Kocher, Sabine Adler, PM Villiger	7
15	Chronic NSAID use and long-term decline of renal function in a prospective rheumatoid arthritis cohort study 2013 ·Annals of the Rheumatic Diseases ·Burkhard Möller, Menno Pruijm, Sabine Adler, Almut Scherer, Peter M. Villiger, Axel Finckh	63
16	Protective effect of A/H1N1 vaccination in immune-mediated disease--a prospectively controlled vaccination study 2011 ·Lara D. Veeken ·Sabine Adler, Anne Krivine, (unknown), Flore Rozenberg, Odile Launay, (unknown), L Guillevin, Peter M. Villiger	68
17	Rapid induction of remission in large vessel vasculitis by IL-6 blockade 2011 ·Swiss Medical Weekly ·(unknown), Stephan Reichenbach, Harald Bonél, Sabine Adler, Felix Wermelinger, PM Villiger	137
18	Behçet's disease: Successful treatment with infliximab in 7 patients with severe vascular manifestations. A retrospective analysis 2011 ·Arthritis Care & Research ·Sabine Adler, Iris Baumgärtner, Peter M. Villiger	50
19	Induction of T cell response by bluetongue virus core-like particles expressing a T cell epitope of the M1 protein of influenza A virus 1998 ·Medical Microbiology and Immunology ·Sabine Adler, (unknown), Polly Roy, Hans‐Dieter Klenk	14
20	Positive inotropic effects of the beta2-adrenoceptor agonist terbutaline in the human heart: Effects of long-term beta1-adrenoceptor antagonist treatment 1994 ·Journal of the American College of Cardiology ·Rafael F. Schäfers, Sabine Adler, A Daul, (unknown), Magdalene Vogelsang, Hans‐Reinhard Zerkowski, Otto‐Erich Brodde	50

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact